Metal-ion speciation in blood plasma incorporating the water-soluble polymer, polyethyleneimine functionalised with methylenephosphonate groups, in therapeutic radiopharmaceuticals

Radiochimica Acta

Volumn 90, Issue 4, 2002, Pages 237-246

  Jarvis, Neil V ^a   Zeevaart, Jan Rijn ^a   Wagener, Judith M ^a   Louw, Wemer K A ^a   Dormehl, Irene C ^a   Milner, Rowan J ^a   Killian, Elmaré ^a  

^a NECSA   (South Africa)

Author keywords

Blood plasma; Bone cancer; Formation constants; Potentiometry; Therapeutic radiopharmaceuticals; Water soluble polymers

Indexed keywords

HOLMIUM; LEAD 212; LEXIDRONAM SAMARIUM SM 153; METAL ION; POLYETHYLENEIMINE METHYLENE PHOSPHONATE RE 186; POLYETHYLENEIMINE METHYLENE PHOSPHONATE RE 188; POLYETHYLENEIMINE METHYLENE PHOSPHONATE SM 153; POLYETHYLENEIMINE METHYLENE PHOSPHONATE TC 99M; POLYMER; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; STRONTIUM 89; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BONE METASTASIS; BONE TUMOR; CANCER PALLIATIVE THERAPY; DOG; DRUG DELIVERY SYSTEM; MODEL; NONHUMAN; PLASMA; POTENTIOMETRY; SYNTHESIS; TISSUE DISTRIBUTION;

EID: 0036420750     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2002.90.4_2002.237     Document Type: Article

References (28)

1. 153Sm-EDTMP (™Quadramet) granted during March (1997).
2. Jarvis, N. V., Wagener, J. M., Jackson, G. E.: J. Chem. Soc., Dalton Trans. 1411 (1995).
3. Wagener, J. M., Jarvis, N. V.: S. Afr. J. Chem. 48, 85 (1995).
4. May, P. M., Williams, D. R., Linder, P. W.: J. Chem. Soc., Dalton Trans. 588 (1977).
5. Zeevaart, J. R., Jarvis, N.V., Louw, W. K. A., Jackson, G. E., Cukrowsky, I., Mouton, C. J.: J. Inorg. Biochem. 73, 265 (1999).
6. Zeevaart, J. R., Jarvis, N. V., Cukrowski, I., Jackson, G. E.: S. Afr. J. Chem. 50, 189 (1997).
7. Cukrowski, I., Zeevaart, J. R., Jarvis N. V.: Anal. Chim. Acta 379, 217 (1999).
8. Zeevaart, J. R., Jarvis, N. V., Louw, W. K. A., Jackson, G. E.: J. In-org. Biochem. 83, 57 (2001).
9. Bijvoet, O. L. M., Fleisch, H. A., Canfield, R. E., Russell, R. G. G. (Eds.): Bisphosphonate on Bones. Elsevier, Amsterdam (1995).
10. Duncan, R., Kopeček, J.: Adv. Polym. Sci. 57, 51 (1984).
11. Soyez, H., Schacht, E.: Pharmaceutical Technology Europe. November (1999) p. 50.
12. Seymour, L. W.: CRC Crit. Rev. Ther. Drug Carrier Syst. 9, 249 (1992).
13. Dormehl, I. C., Louw, W. K. A., Milner, R. J., Kilian, E., Schneeweiss, F. H. A.: Drug Res. 51, 258 (2001).
14. Jarvis, N. V., Wagener, J. M.: Talanta 42, 219 (1995).
15. May, P. M., Murray, K.: Talanta 35, 927 (1988) and references therein.
16. Hassfiell, S. P., Hoff, P., Bruland, Ø. S., Alstad J.: J. Labelled Compd. Radiopharm. 34, 717 (1994).
17. Moedritzer, K., Irani, R. R.: J. Org. Chem. 31, 1603 (1966).
18. Martell, A. E., Smith R. M.: Critical Stability Constants. Vols. 3 and 6. Plenum, New York (1977 and 1989) and references therein.
19. Goeckeler, W. F., Edwards, B., Volkert, W. A., Holmes, R. A., Simon, J., Wilson, D.: J. Nucl. Med. 28, 176 (1987).
20. Woolfenden, J. M., Hall, J. N., Barber, H. B., Wacks, M. E.: Int. J. Nucl. Med. Biol. 10, 251 (1983).
21. Turner, J. H., Martindale, A. A., de Witt, G. C., Webb, J., Sorby, P., Boyd, R. E.: Eur. J. Nucl. Med. 13, 432 (1987).
22. Tse, J. W., Wiebe, L. I., Noujaim, A. A.: Nucl. Med. Biol. 16, 17 (1989).
23. Neumaier B., Rösch F.: Radiochim. Acta 84, 201 (1999).
24. Durbin, P. W., Asing, C. W., Johnston, M. E., Hamilton, J. G., Williams, M. H.: USAEC Report. ORINS-1 (1956) p. 171.
25. O'Mara, R. E., McAfee, J. G., Subramanian, G.: J. Nucl. Med. 10, 49 (1968).
26. Ferro-Flores, G., Garcia-Salinas, L., López, M., González-Zavala, M. A., Tendilla, J. I., López-Gómez, M. A.: J. Radioanal. Nucl. Chem. 222, 93 (1997).
27. Prabhkar, G., Joshi, S. H., Ranganatha, D. K., Umamaheswari, S., Ananthakrishnan, M., Ramamoorthy, N.: Nucl. Med. Biol. 27, 353 (2000).
28. Neves, M.: personal communication.